Epidarex Capital is a leading transatlantic venture capital firm that invests in early-stage, high-growth life science opportunities in under-ventured markets. Epidarex funds groundbreaking research, often building companies from scratch, to address large unmet medical needs with solutions that provide significant benefits to patients.
2010
Privately held
High-risk tolerance, as the firm focuses on early-stage, high-growth investments in innovative and transformative life science technologies.
Bethesda, Md, United States
About
Mission
Epidarex provides equity capital to start-ups, including university spin-outs, by leveraging extensive scientific and industry networks to identify transformative life science investments in overlooked regions.
Values
Innovation, collaboration, and fostering shared success.
Track Record
Team Experience
Experienced professionals with a strong scientific and industry network.
Notable Achievements
Successful investments include Apellis Pharmaceuticals (NASDAQ-listed) and others in their portfolio.
Project Track Record
Investments in groundbreaking life science companies like AdoRx Therapeutics, Apellis Pharmaceuticals, and others.
Get Full Profile
Access complete investment history, team details, portfolio companies, and direct contact information.
Unlock Full AccessHeadquarters
Bethesda, Md, United States
Access 150,000+ investor profiles
Get complete access to our database of investment firms with detailed profiles, contact information, investment preferences, and AI-powered matching.